Joint Formulary & PAD

Dydrogesterone - Menopausal disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

This drug has not been assessed for inclusion on the formulary. Please contact your pharmacy team for advice.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dydrogesterone
Indication :
Menopausal disorders
Group Name :
Keywords :
Menopause, menopausal symptoms, HRT, hormone replacement therapy, progesterone analogue, progestogen, adjunctive progestogen, endometrial protection
Brand Names Include :
Nalvee
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.